Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021

Abstract Background Therapeutic efficacy studies (TESs) and detection of molecular markers of drug resistance are recommended by the World Health Organization (WHO) to monitor the efficacy of artemisinin-based combination therapy (ACT). This study assessed the trends of molecular markers of artemisi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Catherine Bakari, Celine I. Mandara, Rashid A. Madebe, Misago D. Seth, Billy Ngasala, Erasmus Kamugisha, Maimuna Ahmed, Filbert Francis, Samwel Bushukatale, Mercy Chiduo, Twilumba Makene, Abdunoor M. Kabanywanyi, Muhidin K. Mahende, Reginald A. Kavishe, Florida Muro, Sigsbert Mkude, Renata Mandike, Fabrizio Molteni, Frank Chacky, Dunstan R. Bishanga, Ritha J. A. Njau, Marian Warsame, Bilali Kabula, Ssanyu S. Nyinondi, Naomi W. Lucchi, Eldin Talundzic, Meera Venkatesan, Leah F. Moriarty, Naomi Serbantez, Chonge Kitojo, Erik J. Reaves, Eric S. Halsey, Ally Mohamed, Venkatachalam Udhayakumar, Deus S. Ishengoma
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-03-01
Col·lecció:	Malaria Journal
Matèries:	Malaria Molecular markers Therapeutic efficacy studies Plasmodium falciparum kelch 13 (k13) Plasmodium falciparum multidrug resistance 1 (pfmdr1) Plasmodium falciparum
Accés en línia:	https://doi.org/10.1186/s12936-024-04896-0
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!